Eligibility criteria
Condition
Fibromyalgia
Sex
Females and Males
Age
18 + years
Inclusion criteria
Show details
- Patients must have met the inclusion criteria for the preceding fibromyalgia Protocol
A0081056
- Must have received pregabalin/placebo under double-blind conditions.
Exclusion criteria
Show details
- Patients may not participate in the study if they experienced a serious adverse event
during the previous fibromyalgia Study A0081056 which was determined to be related to
the study medication by the investigator or the sponsor.